Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 19 open reading frame 2 pseudogene
- Molecular classification
- Other, pseudogene, non-coding RNA, not protein-coding
01
Overview
This target is a non-coding pseudogene annotated as chromosome 19 open reading frame 2 pseudogene (LOC100533679), mapped in the human genome (Ensembl: ENSG00000234726). Pseudogenes are genomic DNA sequences similar to functional genes but generally lack the ability to encode proteins due to disabling mutations (such as frameshifts or early stop codons). While traditionally thought to be nonfunctional, some pseudogenes can affect gene regulation by acting as decoys for microRNAs, producing non-coding RNAs, or other RNA-based regulatory mechanisms. However, pseudogenes like this one are not drug targets, not therapeutic receptors or enzymes, and have no known direct role in disease modulation or biomarker utility. Their principal relevance lies in genomic research or as potential sources of molecular regulatory elements.
- Other names
- LOC100533679C19orf2 pseudogenechromosome 19 open reading frame 2 pseudogene
02
Biological functions
Some pseudogenes may regulate protein-coding genes by acting as microRNA decoys, producing non-coding RNAs, or influencing gene expression through RNA interferencein general, functions remain obscure for most individual pseudogenes and are not well-defined for chromosome 19 open reading frame 2 pseudogene specifically
03
Disease associations
Possible regulatory involvement in cancer and other diseases documented for some pseudogenes, but there is no direct evidence for this pseudogene's role in diseasepseudogenes can sometimes interfere with genetic testing or biomarker assays
04
Safety considerations
Pseudogenes may confound molecular diagnostic assays if their DNA/RNA is inadvertently detected instead of the parent gene, but not a safety concern for therapeutics
Beyond the preview
Go deeper on Chromosome 19 open reading frame 2 pseudogene.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chromosome 19 open reading frame 2 pseudogene.